Member Info for NCTrade

News on many fronts expected with Sunda to announce the signing of a rig contract this month as confirmed in the RNS.

Also Sunda expected to announce the Environmental Permit has now been granted as previously confirmed in the RNS.

Nps4 no worries :-))

Https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview, at 5.38 Vlad confirms the following:

‘The Sky's the limit, we are talking to large pharmaceutical companies who are looking to acquire or license this treatment’

Don’t be very surprised when the deal suddenly lands as he already said this in his recent interview….

The CEO of Hemo is very confident and It’s not a matter of ‘if’ but ‘when’ that deal lands

Https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview, at 5.38 Vlad confirms the following:

‘The Sky's the limit, we are talking to large pharmaceutical companies who are looking to acquire or license this treatment’

Don’t be very surprised when the deal suddenly lands as he already said this in his recent interview….

It’s not a matter of ‘if’ but ‘when’…

The CAR T-cell therapy market will likely exceed USD 16.23 billion by 2026.

Valuation is projected to hit USD 193.6 billion by 2035.

Estimated to grow at a CAGR of 29.80% starting from 2026 to 2035.

North America held a major revenue share of the market in 2024.

The U.S. CAR T-cell market will grow from US$ 2.71 billion in 2025 to US$ 42.61 billion by 2035, at a 30.40% CAGR.

Asia-Pacific is expected to witness the fastest growth in the coming years.

By drug type, the axicabtagene ciloleucel segment dominated the market in 2024.

By drug type, the tisagenlecleucel segment is expected to show lucrative growth during the forecast period.

By indication, the lymphoma segment held the largest revenue share of the market in 2024.

By indication, the acute lymphocytic leukemia segment is expected to account for the highest growth in the upcoming years.

By end-user, the hospitals segment led the market in 2024.

By end-user, the cancer treatment centers segment is expected to expand rapidly in the forecast years.

Andy Butlers message was clear:

Chuditch represents a new chapter of opportunity, driven by partnership, confidence in the subsurface, and belief in Timor-Leste’s offshore potential.

A powerful statement of intent for the country’s growing gas future.

News on many fronts expected with Sunda due to announce the signing of a rig contract before the end of 2025.

Also expecting Sunda to announce the Environment Permit has been granted anytime now.

Investors know the below are due anytime now so taking their positions for the expected re-rate:

Sunda is on track to sign a rig contract before the end of 2025.

The Environmental Permitting process is progressing well and SundaGas anticipates award during Q4 2025.

If it is company will surely issue an RNS

No fancy tech lol just straight forward google checked

This is what comes up when I googled:

Hemogenyx Ash 2025:

Hemogenyx Pharmaceuticals will present an abstract at the 67th American Society of Hematology (ASH) Annual Meeting which is being held from December 6-9, 2025, in Orlando, Florida.

Hemogenyx at ASH 2025

Hemogenyx Pharmaceuticals has announced that it will have an abstract presented at the 2025 ASH Annual Meeting. Abstracts presented at the meeting feature cutting-edge research and are considered leading presentations in the field of hematology.

The presentation is expected to provide updates on its therapies for blood diseases, likely including its lead clinical program, HG-CT-1, an autologous CAR-T cell therapy for the treatment of relapsed/refractory acute myeloid leukemia (r/r AML) in adults. Preclinical experiments of the company's bispecific antibody therapy have already shown promising results.

Investors and industry leaders anticipate that data revealed at the meeting could influence potential partnerships or funding opportunities for the company, as the ASH meeting is a major event for showcasing new developments in hematological malignancies research.

Lostapound digitt

Googled it, try it for yourself

Https://www.offshore-energy.biz/greater-sunrise-on-southeast-asias-gas-horizon-woodside-strikes-deal-for-lng-concept/

Hemogenyx Pharmaceuticals will have an abstract presented at the 67th American Society of Hematology (ASH) Annual Meeting in Orlando, Florida, which will be held from December 6-9, 2025.

Https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview, at 5.38 he confirms the following:

‘The Sky's the limit, we are talking to large pharmaceutical companies who are looking to acquire or license this treatment’

Don’t be very surprised when the deal suddenly lands as he already said this in his recent interview….

It’s not a matter of ‘if’ but ‘when’…

As Warren Buffet once said:

‘the stock market is a device for transferring money from the impatient to the patient’

In life nobody works for free, and neither are the derampers who spend all day hogging this one board from the break of dawn to when the sun sets…

They have ulterior motives and it’s very clear for everyone to see…

They’re trying to talk this down as much as possible in order to get their entry price then suddenly claim: ‘oh but never attacked the science because it’s absolutely brilliant’…

They are using every scare mongering tactics as they possibly can in order to get some holders to sell and bring the share down for their entry price.

Vlad said it himself he is talking to large pharmaceutical companies in the video I shared and the value of car-t is multiples and multiples of today’s price…listen to the scientist and make a decision :-))))

Https://m.youtube.com/watch?v=HS26Z1ELGU0

Watch the interview, at 5.38 he confirms the following:

‘The Sky's the limit, we are talking to large pharmaceutical companies who are looking to acquire or license this treatment’

A deal with a pharma could drop any day and you’d look back wondering if only you had bought in :-)))

Don’t give your shares away to the derampers who are waiting on the sidelines to buy back in as cheap as possible then go ultra positive…

The drop overdone, gift of a price and fill your boots time

Check out that MEGA sized BUY…

Full CASH paid….

Sunda is on track to sign a rig contract before the end of 2025.

The Environmental Permitting process is progressing well and SundaGas anticipates award during Q4 2025.

:-)))

AB looks very pleased to be there

Ducks all lining up, and re-rate time fast approaching.

Take your positions :-)))